Autophagy induction as a therapeutic strategy for neurodegenerative diseases.

@article{Djajadikerta2019AutophagyIA,
  title={Autophagy induction as a therapeutic strategy for neurodegenerative diseases.},
  author={Alvin Djajadikerta and Swati Keshri and Mariana Pavel and Ryan Prestil and Laura Ryan and David C. Rubinsztein},
  journal={Journal of molecular biology},
  year={2019}
}
Targeting autophagy, oxidative stress, and ER stress for neurodegenerative diseases treatment.
Autophagy in Multiple Sclerosis: Two Sides of the Same Coin
TLDR
This review summarizes the current knowledge about autophagy in MS, in particular how it contributes to the understanding of MS pathology and its potential as a novel therapeutic target.
Natural Compounds and Autophagy: Allies Against Neurodegeneration
TLDR
This review focuses on the role of dietary phytochemicals as modulators of autophagy to fight Alzheimer's and Parkinson’s diseases, fronto-temporal dementia, amyotrophic lateral sclerosis, and psychiatric disorders.
Potentials of autophagy enhancing natural products in the treatment of Parkinson disease
TLDR
The discovery of small molecules or natural products capable of enhancing autophagy mechanism could be a promising strategy for PD treatment as it provides symptomatic relieve for motor symptoms without significant improvement in non-motor complications.
Golgi Apparatus: A Potential Therapeutic Target for Autophagy-Associated Neurological Diseases
TLDR
Target therapies aimed at protecting the Golgi or regulating Golgi proteins might prevent or ameliorate autophagy-related neurological diseases, as well as investigate the potential application of Golgi therapy in autophagic-based neurological diseases.
Bi-Directional Relationship Between Autophagy and Inflammasomes in Neurodegenerative Disorders.
TLDR
The structural basis of inflammasome activation and the mechanistic ideas of the autophagy process in NDs are discussed and a perspective on pharmacological opportunities in this molecular interplay pertaining to NDs is presented.
The Emerging Roles of Autophagy in Human Diseases
TLDR
Advances in understanding the roles of autophagy in human diseases and the therapeutic methods targeting autophapy are summarized and some of the remaining questions in this field are discussed, focusing on cancer, neurodegenerative diseases, infectious diseases and metabolic disorders.
Dying by fire: noncanonical functions of autophagy proteins in neuroinflammation and neurodegeneration
TLDR
Together, these studies illustrate an important role for microglial LANDO in regulating CNS immune activation and protection against neurodegeneration and could have significant impact in furthering the authors' understanding of not only CNS diseases like AD, but likely beyond.
KDM1A/LSD1 as a promising target in various diseases treatment by regulating autophagy network.
  • T. Ma, Anqi Li, Hongmin Liu
  • Biology, Chemistry
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
  • 2022
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 271 REFERENCES
The role of autophagy in neurodegenerative disease
TLDR
An overview of the role of autophagy in neurodegenerative disease is provided, focusing particularly on less frequently considered lysosomal clearance mechanisms and their considerable impact on disease.
Small molecule enhancers of autophagy for neurodegenerative diseases.
TLDR
Various autophagy-inducing small molecules that have emerged in the past few years that may be leads towards the treatment of neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease are discussed.
Autophagy Upregulation as a Therapeutic Strategy for Neurodegenerative Diseases
TLDR
Recent progress in upregulating autophagy as a therapeutic approach in models of neurodegenerative diseases is highlighted, which may guide further studies in the clinic.
A small-molecule scaffold induces autophagy in primary neurons and protects against toxicity in a Huntington disease model
TLDR
A structure/activity analysis with structurally similar compounds approved by the US Food and Drug Administration revealed a defined pharmacophore for inducing neuronal autophagy, an N10-substituted phenoxazine that was neuroprotective and decreased the accumulation of diffuse and aggregated misfolded protein in neurons.
Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice
TLDR
The results suggest that the continuous clearance of diffuse cytosolic proteins through basal autophagy is important for preventing the accumulation of abnormal proteins, which can disrupt neural function and ultimately lead to neurodegeneration.
Therapeutic effects of remediating autophagy failure in a mouse model of Alzheimer disease by enhancing lysosomal proteolysis
TLDR
Lysosomal remediation prevented the marked learning and memory deficits in TgCRND8 mice and underscores the pathogenic significance of autophagic-lysosomal dysfunction in AD and demonstrates the value of reversing this dysfunction as an innovative therapeutic strategy for AD.
Calpain inhibition mediates autophagy-dependent protection against polyglutamine toxicity
TLDR
It is demonstrated, in Drosophila, that calpain knockdown protects against the aggregation and toxicity of proteins, like mutant huntingtin, in an autophagy-dependent fashion, and overexpression of the calpain inhibitor, calpastatin, increases autophagosome levels and is protective in a mouse model of Huntington’s disease.
HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS
TLDR
It is shown that autophagy acts as a compensatory degradation system when the UPS is impaired in Drosophila melanogaster, and that histone deacetylase 6 (HDAC6), a microtubule-associated de acetylase that interacts with polyubiquitinated proteins, is an essential mechanistic link in this compensatory interaction.
...
1
2
3
4
5
...